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Abstract 
Purpose of review:  
This review aims to integrate data on brain dysmaturation and acquired brain injury in 
fetuses and neonates with congenital heart disease, including the contribution of 
cardiovascular physiology, the relation to functional outcome and future preventive 
and regenerative strategies. 
 
Summary: The antenatal and neonatal period is critical for brain development, and 
the brain is particularly vulnerable to hemodynamic disturbances during this time. As 
such, brain dysmaturation and acquired brain injury have consequences for long-term 
neurodevelopment. In critical congenital heart disease, brain dysmaturation and 
injury coexist. Altered cerebral perfusion and decreased cerebral oxygen delivery in 
the antenatal period have impact on brain development, and postnatal hemodynamic 
fluctuations cause additional brain injury. In compromised fetuses and neonates, MR 
imaging is an important and valuable tool to detect altered brain development and 
acquired brain injury. MRI findings can be used to evaluate potential clinical risk 
factors for brain dysmaturation and injury, and are also of value in the prediction of 
neurodevelopmental outcome at an early stage. Information on timing of brain 
dysmaturation and acquired brain injury can be used to develop neuroprotective and 
regenerative strategies. 
 
Running title:  
Neuroimaging in congenital heart disease 
What this paper adds 
- What is the value of functional and structural neuroimaging in detecting brain 
dysmaturation and acquired brain injury in fetuses and neonates with 
congenital heart disease, and what are the future therapeutic and prognostic 
perspectives? 
- How does cardiovascular physiology contribute to the differences in brain 
maturation and acquired brain injury? 
- Can the range of functional outcomes seen in children with congenital heart 
disease be explained by brain dysmaturation and acquired brain injury in the 
fetal and neonatal period? 
-  
Key messages for clinical practice 
Neuroimaging is important in fetuses and neonates at risk of neurodisability due to 
brain developmental disturbances and injury. Using different MR sequences 
structural and functional brain development in addition to aberrant development and 
acquired brain injury can be detected.  
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Abbreviations 
ADC  Apparent diffusion coefficient 
ASL  Arterial spin labeling 
CGM  Cortical gray matter 
CHD  Congenital heart disease 
CoA  Coarctation of the aorta 
dMRI  Diffusion MRI  
FA  Fractional anisotropy 
HLHS  Hypoplastic left heart syndrome 
MRI  Magnetic resonance imaging 
NAA  N-acetyl aspartate 
SVP  Single ventricle pathology (all forms of univentricular CHD) 
TGA  Transposition of the great arteries 
WM  White matter 
WMI  White matter injury 
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Introduction 
With the increasing survival of young infants with congenital heart disease (CHD) the 
focus shifts towards the long-term future of these patients, unfortunately revealing a 
high risk of impaired neurodevelopment  (1). Although literature on this topic is 
contradictory, most recent studies with comparison to healthy controls confirm the 
reverse outcome in this group. As surgical techniques and intensive care improve, 
more of the high-risk patients will nowadays survive. At the age of 14 months, 
psychomotor- and cognitive development indices are lower than normative means in 
patients with single ventricle pathology (2, 3). At school age, lower intelligence 
quotients than in the average population are measured in CHD survivors (4). In 
adolescence, CHD patients still show lower intelligence quotients than their healthy 
peers (5) accompanied with poorer perceptual reasoning and working memory (5, 6). 
Unfortunately, psychiatric disorders as autism and hyperactivity disorder have been 
noticed in higher incidences in adolescents born with critical CHD (7, 8). This 
warrants further investigation to optimize therapeutic and preventive strategies and 
improve neurological outcome in this patient population.  
Important phases of brain development take place in the last part of gestation and 
early postnatal life, at both  (micro)structural and functional level. This includes 
increase in brain size, cortical folding, neuronal migration, synaptogenesis, the onset 
of myelination and cortical activity. The developing brain is particularly vulnerable to 
hemodynamic disturbances, hypoxia and inflammation. . In CHD the fetal circulation 
has anatomically changed, disturbing optimal brain blood content and brain perfusion 
(9). Persistently decreased oxygen delivery to the brain causes metabolic, structural 
and functional adaptions in the fetal brain. Postnatally, when the brain is still under 
development, neonates with critical CHD are exposed to several high-risk events with 
the potential to cause acquired brain injury. These events can cause fluctuations in 
cerebral perfusion which is related to subsequent brain damage. With different 
sequences, MRI has the ability to provide insight into brain development and 
acquired brain injury in compromised fetuses and neonates. In figure 1 an overview is 
presented with the most useful timing and indications of different MRI sequences.  
This review aims to integrate data on brain dysmaturation and acquired brain injury in 
fetuses and neonates with congenital heart disease, including the contribution of 
cardiovascular physiology, the relation to functional outcome and future preventive 
and regenerative strategies. 
 
 
Fetal and neonatal cardiovascular physiology and brain blood supply 
The fetal circulatory system has the optimal design to deliver highly oxygenated 
blood from the placenta to the brain. In the normal fetal circulation, around 25% of 
the ventricular output will flow to the brain and the brain takes 50% of the total fetal 
oxygen consumption (10). An anatomical change in fetal circulation will have 
consequences for brain blood content and brain perfusion. Congenital heart 
malformations develop from the 6-7th week of gestation onwards and alterations in 
cardiac output are already noticed in the second trimester of pregnancy . In utero, a 
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right-to-left shunt is normally present, securing oxygenated and nutrient-rich placental 
blood to flow to the left ventricle, and out the aortic valve to the brain and other 
organs. Two shunts are known; the foramen ovale between the two atria and the 
ductus Botalli (i.e. ductus arteriosus) between pulmonary artery and aorta.  
In many of the critical cardiac defects, the anatomical change will lead to 
disturbances in this right-to-left shunt causing mixed or low blood content delivery to 
the brain. In the situation of left outflow tract obstruction (Hypoplastic left heart 
syndrome (HLHS), aortic valve stenosis) the internal carotid arteries are supplied via 
retrograde flow from the ductus Botalli (normally antegrade flow from the left 
ventricle) with mixed blood content. A change in right-to-left shunt is also seen in 
other types of single ventricle pathology (SVP) with hypoplastic right of left ventricle. 
In transposition of the great arteries (TGA), the aorta is connected to the right 
ventricle causing a left-to-right shunt, resulting in mixed blood content delivery to the 
brain (11). Brain perfusion can also be altered as now the right ventricle has to 
provide the systemic circulation. In other critical cardiac defects (such as right outflow 
tract obstruction (including hypoplastic right heart and pulmonary atresia), coarctation 
of the aorta (CoA), septal defects and truncus arteriosus) the anatomical change 
does not disturb the fetal right-to-left shunt. In many cases the brain can receive 
oxygen- and nutrient-rich blood, but perfusion of the brain can still be suboptimal. 
In late gestation, 10% reduction in oxygen saturation of blood supplied to the brain 
(measured in the major systemic vessels) was described in a group of fetuses (N=30) 
with either left- or right outflow tract obstruction (12). This led to a 15% reduction in 
cerebral oxygen delivery and 32% reduction in oxygen consumption for fetuses with 
CHD compared to their healthy peers (N=30). No differences in fetal cerebral blood 
flow or oxygen extraction were seen.  
The neonatal circulation is different from the fetal circulation, as the pulmonary 
circulation is bypassed in the fetal phase. Therefore with the transition from fetal to 
neonatal life, the type and amount of disturbance in circulation by a specific cardiac 
defect will change. Decrease in pulmonary resistance causes an increase in 
pulmonary flow. In a recent postnatal MRI study (13), performed before surgery, 
cerebral blood flow was comparable between neonates with SVP, TGA, coarctation 
of the aorta (N=32) and healthy controls (N=31). But SVP and TGA had both reduced 
oxygen delivery compared to coarctation of the aorta and healthy controls. As blood 
flow was comparable, this is mainly explained by the decreased arterial oxygen 
saturation: 98% in healthy controls, 98% in coarctation, 84% in SVP, 86% in TGA. 
The previous mentioned critical congenital heart defects require cardiac repair in the 
first weeks of life using cardiopulmonary bypass. The transition from in utero to ex 
utero life (with decrease in pulmonary resistance), perioperative problems (such as 
apneas, hypotension, heart rhythm disorders) and major cardiopulmonary bypass 
surgery are associated with alterations and fluctuations in cerebral perfusion and 
oxygenation, where neonates are known to have less auto regulatory capability and 
anti-oxidant scavenging capacity to cope with such problems. 
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Structural brain development under changed cardiovascular physiology 
 
Infants with critical CHD (requiring neonatal cardiac surgery with cardiopulmonary 
bypass) have smaller head circumferences at birth than healthy controls (17), and 
lower z-scores in fetal head circumference and bi-parietal diameter are already seen 
from the second trimester onwards (18). With the ability to obtain volumes of specific 
brain structures, MRI studies reveal which brain tissues are responsible for smaller 
head circumferences.   
Table 1 provides an overview of fetal and neonatal brain volume studies in mixed 
cohorts of critical CHD. All studies show significant reductions in volume of the total 
brain, white matter (WM) and cortical gray matter (CGM) in CHD fetuses and CHD 
neonates when compared to controls (12, 13, 19, 20). In antenatal studies, with 
increasing gestation higher deviation of total brain volume in CHD is seen (21-23). An 
imaging example of different brain volumes obtained with MRI is provided in figure 2. 
 
In the fetal phase, reduced flow through the systemic ventricle (measured with 
echocardiography) is associated with smaller total volume of the brain (23). This is 
most pronounced in HLHS and TGA, as lower brain volume was also associated with 
with lower combined ventricular cardiac output, or absence of antegrade flow through 
the aortic valve. Also, reduction in oxygen delivery and oxygen consumption is 
associated with decreased total brain volume (12), which is most severe in HLHS 
when compared to biventricular pathology.  
CGM and WM show reductions in volume of at least 10% in HLHS from the 30th week 
onwards (24) but also in tetralogy of fallot (21). No CHD category analyses have 
been done regarding CGM and WM in prenatal studies. In neonatal studies, WM and 
CGM are comparably reduced in TGA and SVP (20, 25). As both structures occupy 
one third of the intracranial space, these explain the majority of reduced total brain 
volume. The cerebral cortex is one of the structures with relatively the highest 
volumetric increase in the last part of gestation and might therefore be relatively more 
affected than other brain structures (26).  
Structural maturation of the cortex is expressed in degree of cortical folding (i.e. 
gyrification). The fetal brain is still smooth around 24 weeks, and cortical folding 
occurs rapidly in the last part of gestation, with at term the cortex being reorganized 
into a pattern close to that of the adult brain (27). Fetal and neonatal cortical folding 
is delayed in fetuses and neonates with SVP compared to healthy controls (24, 25, 
28), as is shown in table 1. An example of cortical folding measurement using MRI is 
provided in figure 2. Less complex sulci (delayed first appearance or reduced depth) 
can already be seen in HLHS fetuses around 30 weeks of gestation (24). Neonates 
with TGA (N=21) show comparable degree of cortical folding as healthy controls (25). 
In both SVP and TGA, mixed blood content delivery is supplied to the brain. But in 
HLHS, the aortic arch (supplying the internal carotid arteries) has retrograde 
perfusion via the ductus Botalli. Apparently, the latter is playing a larger role in the 
delay in cortical folding. Postoperative cortical folding (2 weeks after surgery, N=31) 
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is negatively influenced by lower birth weight and preoperative balloon 
atrioseptostomy (25). In addition, the basal ganglia and thalami are also known to be 
smaller in SVP and TGA when compared to healthy controls, in both fetal (24) and 
neonatal (20) period. The cerebellum is an important structure undergoing rapid 
(three fold) increase from the 30th week of gestation onwards (26), and is at this age 
of comparable volume in fetuses with and without CHD (21, 22). In the postnatal 
period (before surgery), a reduction of 20% in cerebellar volume in SVP and TGA 
neonates (N=19) has been observed (20).  
 
Smaller postnatal brain volumes are associated with abnormal neurobehavior in CHD 
newborns before their open-heart surgery (30). Although data on the association 
between fetal and neonatal brain volumes and long-term neurodevelopmental 
outcome in critical CHD is lacking, the importance of optimal brain growth has been 
shown. At 1 year of age, WM volume is predictive of language development at the 
same time point in TGA infants. In adolescents with cyanotic congenital heart 
disease, total brain volumes are significantly smaller than in healthy controls, and this 
decrease is strongly correlated with total IQ, verbal comprehension, perceptual 
reasoning and working memory (31). Delays in these cognitive functions are also 
associated with lower hippocampal volume in CHD adolescents (a structure that 
cannot be measured in fetuses and neonates) (32). Studies in preterm infants have 
highlighted the importance of optimal structural volumetric brain growth (33), with 
especially larger WM and cerebellum being related to better cognition and processing 
speed at (pre-)school age. Impairments in cortical folding at term age are known to 
be associated with subsequent alterations in cognitive outcome in preterm neonates 
(34-37). 
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Microstructural white matter maturation: cardiac risk factors and functional 
outcomes 
Many of the maturational processes that take place in the last part of gestation and 
early postnatal life are at microstructural level, for example white matter axonal 
growth and myelination. Improved microstructural development of the white matter is 
associated with higher cognitive functioning, visual-spatial skills and memory in 
adolescents with TGA (8). Also, early life perioperative factors such as gestational 
age, shorter duration of intraoperative cooling, longer intensive care stay after cardiac 
repair and greater number of total operations are predictors of reduced white matter 
microstructure as adolescent (41).  
 
Contrast in diffusion MRI (dMRI) is based on the motion of water molecules (42). The 
diffusion profile of water molecules can vary across the brain due to the high 
complexity of the different biological structures. In the cerebrospinal fluid, water 
molecules are allowed to move relatively freely. Diffusion is described here as being 
isotropic, as the average displacement of water molecules is equal in all directions. In 
the white- and gray matter, water movement is restricted in certain directions by the 
presence of cellular architecture (i.e. axonal density and myelination), causing 
diffusion to be anisotropic. The influence of cerebral tissue on water movement 
enables dMRI to be highly sensitive to microstructural changes, including those 
changes associated with brain development and brain injury. Higher fractional 
anisotropy (FA) in the white matter means increased cellular architecture, i.e. 
increased microstructural development. An example image of diffusion tensor 
imaging, a diffusion sequence with the ability to map the direction of diffusion, is 
provided in figure 2. 
 
The first study using dMRI to examine disrupted postnatal brain development in 
neonates with CHD observed that FA values were lower throughout the brain prior to 
surgery in both SVP and TGA when compared to healthy controls (43). These dMRI 
measures presumably reflect abnormal in utero microstructural brain development. 
Other studies have replicated these findings using a variety of dMRI analysis 
approaches (44-46). Also, postnatal white matter FA is lower in CHD neonates with 
brain injury compared to CHD neonates without brain injury (44). This shows 
dysmaturation of the brain to be accompanied with an increased risk of acquiring 
brain injury in early life.  The corpus callosum is an important white matter structure 
with decreased FA in neonates with TGA (45), which is associated with impaired 
cognitive functioning at pre-school age in preterms (48).  
 
Altered WM microstructure prior to surgery appears to be influenced by smaller aortic 
diameter in the presence of aortic atresia in SVP (49). In contrast, brain 
microstructure is less disrupted in those cases with a prenatal diagnosis, which may 
be due to earlier use of prostaglandin E1 (to maintain the ductus Botalli) (50). The 
functional impact of early microstructural abnormalities identified on dMRI in CHD 
infants has been highlighted recently in a study showing that altered FA values are 
associated with altered functional connectivity using electroencephalography prior to 
surgery (51). This shows the relation between structural and functional brain 
development.  
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Structural and functional brain networks in congenital heart disease 
Structural connections between different brain regions can be estimated using dMRI 
based tractography, and together be placed in the context of a network, or graph. 
Graph theory provides a mathematical framework for the analysis of structural brain 
networks. Most commonly, important nodes are defined on the basis of degree 
(i.e.the number of connections to other nodes) or centrality (i.e.the probability that 
pathways between other nodes pass at least once through the node of interest) (52). 
Graph-theoretical, structural connectivity analyses have demonstrated that network 
connectivity is present at term age. In preterm infants, the presence of well-
connected cortical hubs are already evident at 30 weeks gestation (53). These hubs 
display a high degree of connectivity and, even at this early age, form a densely 
connected subnetwork, forming a putative “rich club” of connections. These clubs are 
centered in the heteromodal association cortex, in the superior frontal and parietal 
lobes, and includenodes in the basal ganglia and hippocampi.  
Functional networks can be examined using functional resting state MRI. We know 
from work in the developing preterm brain that functional networks are present in 
newborns and closely resemble those reported in adults (54, 55). Evidence suggests 
functional development to proceed according to well-established hierarchy. Although 
the presence of executive networks, including the default mode and fronto-parietal 
attentional networks, at such a young age also suggests that foundational network 
activity is established in advance of the cognitive functions that they are thought to 
underlie.  
To date, there have been no reported structural or functional network based studies 
on the neonatal brain in CHD. However, in adolescents, who had undergone repair of 
d-TGA in infancy, disrupted network organization (alterations in network connectivity, 
integration and segregation) was associated with worse ADHD outcomes (56) and 
cognitive dysfunction (57). Further research on structural networks is warranted. 
Functional MRI networks have been explored in CHD adolescents and adults (58, 
59). In a recent study, adolescents who underwent surgery for CHD (n=17) displayed 
altered fMRI activity during a working memory test compared to controls (59). CHD 
subjects exhibited less task-induced deactivation within left precuneus- and right 
inferior frontal cortical area during the task. Importantly, prefrontal fMRI deactivation 
correlated with improved working-memory performance in the CHD group. Future 
studies with larger sample sizes are required to determine the relationship between 
fMRI findings and executive performance in survivors of CHD. 
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Range of acquired neonatal brain injury and contribution to functional outcome 
As shown in figure 1, different types of neonatal acquired brain lesions are seen in 
critical CHD. Acquired neonatal brain injury is in most cases clinically silent 
(especially when sedation is given (61)) highlighting the importance of neuroimaging 
in this group. When of ischemic origin, which is most often the case in CHD, these 
lesions can be seen on dMRI (as shown in figure 2). Brain tissue edema as a 
reaction to ischemia will lead to restriction of water molecular diffusion  which is 
displayed as high intensity on dMRI and with reduced apparent diffusion coefficient 
(ADC) values. Subsequently, pseudo normalization of the ADC will occur and dMRI 
should, therefore, be performed within 3-7 days after injury (62). Table 2 compares 
the incidences of brain injury in SVP and TGA patients. 
White matter injury (WMI) is described in full-term neonates with CHD in remarkably 
high incidences (43). WM lesions are characterized as hypo- and hyper-intense on 
T2- and T1 weighted imaging respectively, and scoring systems differ between 
research groups (63). In CHD, WM lesions can often be found in the watershed areas 
(areas perfused by the most distal branches of two main cerebral arteries) which are 
usually due to (acute) hypo perfusion. In neonates, auto regulatory mechanisms are 
still vulnerable as they lack the full ability to cope with fluctuations in cerebral 
perfusion. In neonates with critical CHD, lower preoperative oxygen saturation and 
preoperative hypotension are associated with increased risk of preoperative WMI 
(64-67), as is postnatal diagnosis of the heart defect (50). Postoperative WMI is 
associated with lower hematocrit and arterial carbondiaoxide during surgery, as also 
post-operative complications and lower mean blood-pressures (64, 68, 69). Patients 
with SVP show longer length of post-operative stay, more additional operations, more 
often cardiopulmonary resuscitation and extracorporal membrane oxygenation than 
patients with TGA (70), but incidences of acquired brain injury are similar between 
the two groups (see table 2).   
Arterial ischemic stroke is thought to have a thromboembolic origin. Cortical and 
deep gray matter focal strokes are common in the CHD population, as is shown in 
table 2. Main branch strokes always include WM, CGM and basal ganglia. After 
cardiopulmonary bypass surgery in CHD newborns, focal infarctions of the basal 
ganglia and CGM are often seen (table 2). Branches of the middle cerebral artery 
seem to be most often involved, followed by the posterior- and anterior cerebral 
artery (68). Balloon atrioseptostomy is associated with preoperative stroke in most 
studies (64, 66, 71, 72) with the main underlying etiology thought to be embolic, but 
disturbances in cerebral perfusion cannot be excluded.  
WM lesions are also characteristic of preterm neonates, which might reflect the 
shared WM vulnerability (and immaturity) between preterm and CHD neonates. 
Preoperative brain injury was found to be accompanied by decreased microstructural 
WM maturation in several studies (44, 46, 64). In preterm infants WMI is thought to 
have an inflammatory origin, but in critical CHD neonates no relationship between 
WMI and inflammatory responses have been observed to date (74, 75). Lower 
postnatal cerebral blood flow (using ASL) is associated with higher incidences of 
preoperative WM abnormalities in CHD neonates with SVP and TGA (16). This 
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suggests a link between abnormal cerebral hemodynamics, brain immaturity and 
acquired brain injury in critical CHD. 
Risk factors as lower birth weight, genetic syndrome, longer mechanical ventilation 
after surgery and postoperative complications are risk factors of delayed 
psychomotor and mental outcome at the age of 14 months. Data on 1770 children 
(ICCON database) revealed longer total support time, extracorporeal membrane 
oxygenation, ventricular assist device support and longer post-operative ICU stay to 
be associated with lower mental and psychomotor scores at the age of 13 months 
(70). But also lower birth weight and genetic syndrome are important risk factors for 
preschool outcome in children with CHD (2). 
The prognosis of acquired brain injury mainly depends on location and extent. 
Involvement of the posterior limb of the internal capsule and cerebral peduncles on 
diffusion MRI is predictive of (unilateral) spastic cerebral palsy, which can already be 
present from 3 months of age onwards (76). Acquired stroke and WMI show a trend 
of relation to lower psychomotor outcome at the age of 2 years (74).The development 
of epilepsy after the neonatal period is reported in various incidences, but normally 
responds well to drug-therapy (77). On the prognosis of cognitive outcome, there is 
less consensus regarding acquired brain injury. This may partly be due to the 
relatively short period of follow-up to date after neonatal surgery for congenital heart 
disease. Lower cognitive scores at the age of 12 months are seen in infants who had 
preoperative acquired brain injury (78).  
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Future perspectives 
This review has shown substantial gaps in current knowledge on the relation between 
early life brain dysmaturation and acquired brain injury with functional outcomes on 
the long-term. Neuroimaging is important in fetuses and neonates with congenital 
heart disease, to reveal the presence of brain dysmaturation and acquired brain 
injury and provide opportunities for early intervention. Close monitoring of the infant, 
child, adolescent and adult with CHD is necessary, as neurodevelopmental 
impairments are common and require additional support. Preschool survivors with 
SVP show similar neurodevelopmental outcomes as children with TGA and other 
types of biventricular physiology (80, 81). This shows the importance of 
neurodevelopmental follow-up in all patients who require cardiac surgery with 
cardiopulmonary bypass in the first weeks of life. Early life neuroimaging and life-long 
follow-up should be combined to reveal the effect of brain alterations in the most 
critical period of brain development to subsequent neurological outcome. The 
interaction between (epi)genetics, cardiovascular physiology and neurological 
development requires further elucidation in the prediction of these patients with the 
highest risk.  
With the identification of the most critical time points of onset of brain dysmaturation 
and acquired brain injury, neuroimaging is fundamental in the development of 
neuroprotective strategies. In other high-risk neonatal populations with hypoxic-
ischemic injury or neonatal stroke, clinical trials are exploring the protective and 
regenerative role of several drugs as allopurinol, EPO, xenon gas and melatonin. 
These drugs might have a beneficial role in the pathways set in motion after fetal or 
neonatal hypoxia and the following reoxygenation and reperfusion (82). Currently, 
allopurinol and EPO are both very attractive candidates. Allopurinol has the ability to 
scavenge free radicals (released after the hypoxic incident), where EPO has an anti-
inflammatory role. Experimental therapies with for example stem cells might also be 
promising in our near future. Fetuses and neonates with critical CHD are 
experiencing both chronic hypoxia as acute hypoxic-ischemic incidents, and might 
benefit from these promising neuroprotective interventions.  
Conclusions 
This review highlights the value of early life structural and functional neuroimaging 
and lifelong follow-up in compromised fetuses and neonates with critical congenital 
heart disease. As major developmental phases take place in the antenatal and 
neonatal period, a time when the brain is particularly vulnerable to hemodynamic 
disturbances, brain dysmaturation and acquired brain injury have consequences for 
long-term cognition, motor outcome, behavior and executive functioning. In critical 
congenital heart disease, brain dysmaturation and brain injury coexist.  Altered 
cerebral perfusion and decreased cerebral oxygen delivery in the antenatal period 
have impact on brain development, and postnatal hemodynamic fluctuations cause 
additional brain injury. Different MR sequences allow examination of functional and 
structural brain development and have the ability to characterize aberrant brain 
development and acquired brain injury. These findings can be helpful in the design of 
therapeutic and preventive strategies aimed at optimizing neurodevelopmental 
outcome.  
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Tables 
Fetal volumes Inclusion Cases n Controls n  
Masoller, 201615 complex & simple CHD 58 58 Reduced TBV. 
Schellen, 201518 ToF 24 24 Reduced TBV, CGMV, WMV. Comparable CBV. 
Sun, 201512 complex CHD 30 30 Reduced TBV 
Andescavage, 201519 complex & simple CHD 41 94 Comparable CBV. 
Clouchoux, 201321 HLHS 18 30 Reduced CGMV, WMV and BGV. Reduced GI and CS. 
Limperopoulos, 201020 complex CHD 50 55 Reduced TBV 
Postnatal volumes     
Lim, 201613 complex CHD 32 31 Reduced TBV 
Rhein, 201517 complex CHD 19 19 Reduced TBV, CGMV, WMV, BGV and CBV 
Ortinau, 201325 complex CHD 15 12 Reduced GI and CS 
Postoperative volumes     
Claessens, 201622 complex CHD 23 18 Reduced CGMV and WMV. Reduced GI and CS. 
 
Table 1: Overview of current literature on brain volume studies in fetuses and neonates with CHD. The studies were included when 
brain volumes or cortical folding was examined using MRI, and patients were compared to healthy controls. When multiple studies 
from one center showed similar results on the same population, only one of those studies was included. CHD: congenital heart 
disease. HLHS: hypoplastic left heart syndrome. ToF: tetralogy of fallot. TBV: total brain volume (only brain structures, excluding 
cerebrospinal fluid). CGMV: cortical gray matter volume. WMV: white matter volume. BGV: basal ganglia volume. CBV: cerebellar 
volume. GI: gyrification index. CS: cortical surface.  
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Preoperative injury   Any injury WMI Infarction 
Studies SVP n TGA n SVP TGA SVP TGA SVP TGA 
Peyvandi, 201642 57 96 35% 39% 28% 29% 12% 25% 
Brossard-Racine, 2016 20 31 45% 29%     
Desai, 201565 13 6   31% 17%   
Bertholdt, 201456 8 22   0% 32%   
Mulkey, 201337 18 14 50% 50%     
Dimitropoulos, 201355 22 71   32% 21% 17% 24% 
Beca, 200963 13 44   23% 27% 8% 5% 
Postoperative new injury     new WMI new Infarction 
Studies     SVP TGA SVP TGA 
Desai, 201565 16 14   75% 29%   
Bertholdt, 201456 8 22   13% 5%   
Dimitropoulos, 201355 29 65   14% 19% 14% 8% 
 
Table 2: Overview of current literature on brain injury in fetuses and neonates with critical CHD. Brain injury studies showing 
numbers for SVP and TGA patients separately were included. When multiple studies from one center showed similar results on the 
same population, only one of those studies was included. CHD: congenital heart disease. SVP: single ventricle pathology. TGA: 
transposition of the great arteries. WMI: white matter injury. 
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Figure legends 
Figure 1: In this figure an overview of normal microstructural (dark purple) and structural (light purple) brain developmental phases 
from the 20th week of gestation until the neonatal period are shown. In the second part cerebral changes (dark blue) and brain 
injuries (light blue) in fetal and neonatal populations at risk for neurodisability are presented. Below each developmental phase or 
alteration the most convenient neuroimaging or neuromonitoring techniques to display the concerning part are shown. *No MRI 
modality, outside the scope of this review.  
Figure 2: This figure shows different MR images and post-processing images of neonates with critical CHD. A and B show T2-
weighted imaging based brain volumes at different axial levels (pink=CGM, blue=unmyelinated WM, purple=brainstem, 
red=cerebellum, light red=cerebral spinal fluid, turquoise=ventricles, green=basal ganglia, yellow=myelinated WM). C shows a 3D 
reconstruction of the inner CGM surface with the mean curvature of this surface (yellow=zero curvature, blue=negative curvature, 
red=positive curvature). Figure A-C are the result of an in-house developed method used in our CHD population (83). D and E are 
results of axial DWI displaying the high intensity of respectively periventricular white matter lesions and bilateral focal infarctions of 
the basal ganglia and thalamus in two CHD patients. In F an example of diffusion tensor imaging in a neonate with critical CHD can 
be found at the axial level of the posterior limb of the internal capsule (blue superior-inferior tracts) and corpus callosum (red left-
right tracts).  
 
 
